EV/EBITDA
-2.28
0.000.00%
Tue, 03 Dec 2024 21:02:30 GMT
Summary:
Acrivon Therapeutics Common Stock EV/EBITDA is currently -2.28, unchanged from the previous trading day. Over the past year, it has dropped by -1.32 (-137.50%). ACRV EV/EBITDA is now -235.29% below its all-time high of -0.68.ACRV EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ACRV EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | 0.0% |
| 1 m1 month | +8.4% |
| 3 m3 months | +23.2% |
| 6 m6 months | +29.2% |
| ytdytd | -91.6% |
| 1 y1 year | -137.5% |
| 5 y5 years | - |
ACRV EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | -1.82 | -25.3% | -2.69 | +15.2% |
| 3 m | 3 months | -1.82 | -25.3% | -3.53 | +35.4% |
| 6 m | 6 months | -1.82 | -25.3% | -3.57 | +36.1% |
| 1 y | 1 year | -0.68 | -235.3% | -4.51 | +49.5% |
| 3 y | 3 years | -0.68 | -235.3% | -14.99 | +84.8% |
| 5 y | 5 years | -0.68 | -235.3% | -14.99 | +84.8% |
| alltime | all time | -0.68 | -235.3% | -14.99 | +84.8% |
Acrivon Therapeutics Common Stock EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -2.28(+91.6%) |
| Date | Value |
|---|---|
| 2023 | -1.19(-83.1%) |
| 2022 | -7.06 |
FAQ
- What is Acrivon Therapeutics Common Stock EV/EBITDA?
- What is the all time high EV/EBITDA for Acrivon Therapeutics Common Stock?
- What is ACRV EV/EBITDA year-to-date change?
- What is Acrivon Therapeutics Common Stock EV/EBITDA year-on-year change?
What is Acrivon Therapeutics Common Stock EV/EBITDA?
The current EV/EBITDA of ACRV is -2.28
What is the all time high EV/EBITDA for Acrivon Therapeutics Common Stock?
Acrivon Therapeutics Common Stock all-time high EV/EBITDA is -0.68
What is ACRV EV/EBITDA year-to-date change?
Acrivon Therapeutics Common Stock EV/EBITDA has changed by -1.09 (-91.60%) since the beginning of the year
What is Acrivon Therapeutics Common Stock EV/EBITDA year-on-year change?
Over the past year, ACRV EV/EBITDA has changed by -1.32 (-137.50%)